Page last updated: 2024-10-24

camostat and Kidney Diseases

camostat has been researched along with Kidney Diseases in 1 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakayama, S1
Koide, H1

Other Studies

1 other study available for camostat and Kidney Diseases

ArticleYear
[Clinical application of proteinase inhibitors to renal diseases].
    Nihon rinsho. Japanese journal of clinical medicine, 1991, Volume: 49, Issue:9

    Topics: Antithrombins; Esters; Free Radical Scavengers; Gabexate; Guanidines; Humans; Kidney Diseases; Prote

1991